Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

The PCOS questionnaire is valid for Indian women, but metformin doesn't significantly improve symptoms beyond oral contraceptives.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Qing Cuo Formula may effectively treat acne by reducing inflammation and hormone levels.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Checking the chin, thighs, upper lip, or lower abdomen is enough to predict hirsutism.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

Disease-specific tools better assess alopecia areata's impact on quality of life.